Education
About Us
Working with TipRanks
Follow Us
Veeva Systems (VEEV)
NYSE:VEEV
VEEV Analyst Ratings
Moderate Buy
17 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VEEV Stock 12 Month Forecast
Average Price Target
$325.29
▲(11.71% Upside)
| Highest Price Target$380.00 | Average Price Target$325.29 | Lowest Price Target$222.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$329→$336
Buy
15.38%
Upside
Reiterated
11/01/25
AI Generated ArticleAI Generated Article
Barclays
$325
Buy
11.61%
Upside
Reiterated
10/17/25
Oppenheimer
$325
Buy
11.61%
Upside
Reiterated
10/17/25
Evercore ISI
$295
Hold
1.30%
Upside
Reiterated
10/17/25
Raymond James
$292.73→$340
Buy
16.76%
Upside
Reiterated
10/17/25
William Blair
―
Buy
―
Reiterated
10/17/25
Stifel Nicolaus
$320
Buy
9.89%
Upside
Reiterated
10/17/25
Morgan Stanley
$222
Sell
-23.76%
Downside
Reiterated
10/17/25
Cautious Outlook for Veeva Systems Amid Uncertainties in AI Strategy and Growth TargetsWe highlight the following takeaways: 1) No meaningful change in current business conditions. Management noted that with 2 weeks left in the quarter Q3 is tracking in line to ahead of guidance, which was widely expected. Veeva also characterized the macro backdrop as healthy, a slight uptick in tone relative to recent quarters and matching recent investor sentiment in Life Sciences. The company reiterated its 2030 target of $6bn in revenue, which bakes in a CAGR of ~13%. The main growth driver through 2030 is expected to be Clinical at ~21% CAGR ( Exhibit 1 ), with broad-based contribution across products such as CTMS, eTMF and EDC. 2) AI was a bigger focus this year. Veeva announced a partnership with Open Evidence to co-create and market a platform called Open Vista.
Needham
$355
Buy
21.91%
Upside
Reiterated
10/17/25
Veeva Systems: Robust Portfolio and Strategic Initiatives Drive Buy RatingWe reiterate our Buy rating, $355 PT on Veeva (VEEV) following the company's 2025 Analyst Day. Management highlighted how the diversified product portfolio is allowing the company to execute towards its 2030 targets, evidenced by an update that management plans to meet or exceed 3Q26 guidance. While investors may be disappointed in the lack of increase to the 2030 targets, we came away incrementally bullish from the rising upside levers: AI agents dominated the spotlight and should roll out in 2025 & 2026, with scaling usage-based monetization thereafter, while the new markets initiative is soon to welcome its first customers, yet the 2030 targets assume no contribution from either initiative. As such, we continue to view the 2030 targets as achievable, if not conservative, leading us to remain buyers of this durable execution story.
Truist Financial
―
Hold
―
Reiterated
10/17/25
Canaccord Genuity
$300
Hold
3.02%
Upside
Reiterated
10/17/25
Bank of America Securities
$304
Hold
4.40%
Upside
Reiterated
10/16/25
RBC Capital
$330
Buy
13.32%
Upside
Reiterated
10/16/25
BTIG
$340
Buy
16.76%
Upside
Reiterated
10/16/25
Unknown Analyst
China Merchants SecuritiesNot Ranked
China Merchants Securities
$351
Buy
20.54%
Upside
Initiated
10/13/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$329→$336
Buy
15.38%
Upside
Reiterated
11/01/25
AI Generated ArticleAI Generated Article
Barclays
$325
Buy
11.61%
Upside
Reiterated
10/17/25
Oppenheimer
$325
Buy
11.61%
Upside
Reiterated
10/17/25
Evercore ISI
$295
Hold
1.30%
Upside
Reiterated
10/17/25
Raymond James
$292.73→$340
Buy
16.76%
Upside
Reiterated
10/17/25
William Blair
―
Buy
―
Reiterated
10/17/25
Stifel Nicolaus
$320
Buy
9.89%
Upside
Reiterated
10/17/25
Morgan Stanley
$222
Sell
-23.76%
Downside
Reiterated
10/17/25
Cautious Outlook for Veeva Systems Amid Uncertainties in AI Strategy and Growth TargetsWe highlight the following takeaways: 1) No meaningful change in current business conditions. Management noted that with 2 weeks left in the quarter Q3 is tracking in line to ahead of guidance, which was widely expected. Veeva also characterized the macro backdrop as healthy, a slight uptick in tone relative to recent quarters and matching recent investor sentiment in Life Sciences. The company reiterated its 2030 target of $6bn in revenue, which bakes in a CAGR of ~13%. The main growth driver through 2030 is expected to be Clinical at ~21% CAGR ( Exhibit 1 ), with broad-based contribution across products such as CTMS, eTMF and EDC. 2) AI was a bigger focus this year. Veeva announced a partnership with Open Evidence to co-create and market a platform called Open Vista.
Needham
$355
Buy
21.91%
Upside
Reiterated
10/17/25
Veeva Systems: Robust Portfolio and Strategic Initiatives Drive Buy RatingWe reiterate our Buy rating, $355 PT on Veeva (VEEV) following the company's 2025 Analyst Day. Management highlighted how the diversified product portfolio is allowing the company to execute towards its 2030 targets, evidenced by an update that management plans to meet or exceed 3Q26 guidance. While investors may be disappointed in the lack of increase to the 2030 targets, we came away incrementally bullish from the rising upside levers: AI agents dominated the spotlight and should roll out in 2025 & 2026, with scaling usage-based monetization thereafter, while the new markets initiative is soon to welcome its first customers, yet the 2030 targets assume no contribution from either initiative. As such, we continue to view the 2030 targets as achievable, if not conservative, leading us to remain buyers of this durable execution story.
Truist Financial
―
Hold
―
Reiterated
10/17/25
Canaccord Genuity
$300
Hold
3.02%
Upside
Reiterated
10/17/25
Bank of America Securities
$304
Hold
4.40%
Upside
Reiterated
10/16/25
RBC Capital
$330
Buy
13.32%
Upside
Reiterated
10/16/25
BTIG
$340
Buy
16.76%
Upside
Reiterated
10/16/25
Unknown Analyst
China Merchants SecuritiesNot Ranked
China Merchants Securities
$351
Buy
20.54%
Upside
Initiated
10/13/25
Best Analysts Covering Veeva Systems
1 Month
xxx
Success Rate
16/25 ratings generated profit
Average Return
+1.91%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.00% of your transactions generating a profit, with an average return of +1.91% per trade.
3 Months
xxx
Success Rate
12/18 ratings generated profit
Average Return
+4.21%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.21% per trade.
1 Year
Success Rate
18/18 ratings generated profit
Average Return
+19.63%
reiterated a buy rating 2 months ago
Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.63% per trade.
2 Years
xxx
Success Rate
18/18 ratings generated profit
Average Return
+27.57%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +27.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VEEV Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
28
30
34
35
40
Hold
11
11
12
11
14
Sell
2
1
2
2
3
Strong Sell
0
0
0
0
0
total
41
42
48
48
57
Each month's total comprises the sum of three months' worth of ratings.
VEEV Financial Forecast
VEEV Stock Forecast FAQ
What is VEEV’s average 12-month price target, according to analysts?
Based on analyst ratings, Veeva Systems’s 12-month average price target is 325.29.
What is VEEV’s upside potential, based on the analysts’ average price target?
Veeva Systems has 11.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VEEV a Buy, Sell or Hold?
Veeva Systems has a consensus rating of Moderate Buy which is based on 17 buy ratings, 5 hold ratings and 1 sell ratings.
What is Veeva Systems’s price target?
The average price target for Veeva Systems is 325.29. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $380.00 ,the lowest forecast is $222.00. The average price target represents 11.71% Increase from the current price of $291.2.
The highest analyst price target is $380.00 ,the lowest forecast is $222.00. The average price target represents 11.71% Increase from the current price of $291.2.
What do analysts say about Veeva Systems?
Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of VEEV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.